Company Filing History:
Years Active: 1985-1987
Title: The Innovative Contributions of San-Bao Hwang
Introduction
San-Bao Hwang is a notable inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the Platelet-Activating Factor (PAF). With a total of 5 patents to his name, Hwang's work has the potential to impact various medical conditions.
Latest Patents
Hwang's latest patents include the development of substituted 2,3,3a,6-tetrahydro-6-oxobenzofuran derivatives. These compounds have been shown to possess potent and specific PAF antagonistic activities, making them useful in treating diseases mediated by PAF. Such conditions include pain, fever, inflammation, cardiovascular disorders, asthma, lung edema, allergic disorders, skin diseases, psoriasis, toxic shock syndrome, and adult respiratory distress syndrome. Another significant patent involves indene derivatives, which also demonstrate potent PAF antagonistic activities and are beneficial in treating similar medical conditions.
Career Highlights
San-Bao Hwang is currently employed at Merck & Company, Inc., where he continues to innovate and contribute to the field of pharmaceutical research. His work at Merck has allowed him to explore various therapeutic avenues and develop new treatments for pressing health issues.
Collaborations
Hwang has collaborated with esteemed colleagues such as Tsung-Ying Shen and Tesfaye Biftu. These collaborations have fostered a productive environment for research and development, leading to advancements in their shared field of expertise.
Conclusion
San-Bao Hwang's contributions to medicinal chemistry and his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for new treatments that address critical health challenges.